Westfield Capital Management CO LP Bicycle Therapeutics PLC Transaction History
Westfield Capital Management CO LP
- $21.9 Billion
- Q3 2025
A detailed history of Westfield Capital Management CO LP transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Westfield Capital Management CO LP holds 2,952,543 shares of BCYC stock, worth $19.1 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,952,543
Previous 2,657,305
11.11%
Holding current value
$19.1 Million
Previous $22.6 Million
1.29%
% of portfolio
0.1%
Previous 0.12%
Shares
7 transactions
Others Institutions Holding BCYC
# of Institutions
107Shares Held
38MCall Options Held
37.7KPut Options Held
3.7K-
Baker Bros. Advisors LP New York, NY10.9MShares$70.5 Million0.69% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$22.4 Million5.34% of portfolio
-
Armistice Capital, LLC New York, NY2.98MShares$19.3 Million0.35% of portfolio
-
Siren, L.L.C. New York, NY2.01MShares$13 Million0.61% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR1.42MShares$9.19 Million0.41% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $192M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...